Clinical Trials Logo

Pregnancy Related clinical trials

View clinical trials related to Pregnancy Related.

Filter by:

NCT ID: NCT04482504 Active, not recruiting - Pregnancy Related Clinical Trials

Balance Disorders Related to Pregnancy

PRST
Start date: October 1, 2019
Phase:
Study type: Observational

Primary aim of this study is to evaluate postural equilibrium and risk of falls during pregnancy by comparing static postural stability between pregnant and non-pregnant control women. Secondary aim is to find out predisposing factors of falling during pregnancy using by validated questionnaires focused on exercise activities and self-evaluation of postural stability. The investigators also determine level of vitamin D in the blood.

NCT ID: NCT04449432 Active, not recruiting - Clinical trials for Overweight and Obesity

Goals for Reaching Optimal Wellness: GROWell

Start date: December 14, 2020
Phase: N/A
Study type: Interventional

Despite the negative consequences to maternal-child health from women gaining too much weight during pregnancy, up to 62% of overweight and obese women gain more pregnancy weight than is recommended. This project will establish the efficacy of Goals for Reaching Optimal Wellness (GROWell), an mHealth tool for achieving appropriate pregnancy weight gain and promoting postpartum weight loss among women who enter pregnancy overweight or obese. GROWell will fill a gap in research and clinical care by providing a validated, standalone mHealth tool for weight control during pregnancy and postpartum, which is a currently lacking resource.

NCT ID: NCT04444518 Active, not recruiting - Pregnancy Related Clinical Trials

Increasing Influenza and Tdap Vaccination of Pregnant Women

Start date: November 11, 2020
Phase: N/A
Study type: Interventional

Pregnant women who get influenza are more likely than non-pregnant women to have serious complications, including hospitalizations, death, preterm labor and premature birth. Pertussis can cause hospitalization or death for newborns. However, influenza and Tdap vaccination rates for pregnant women are low nationally. In this study, the investigators will perform a randomized controlled trial aimed at practice change in obstetricians' offices, with an overall goal of reducing morbidity and mortality from influenza and pertussis infections.

NCT ID: NCT04388605 Active, not recruiting - Pregnancy Related Clinical Trials

Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic

ASPIRE
Start date: April 21, 2020
Phase:
Study type: Observational [Patient Registry]

Prospective nationwide cohort study of pregnant women enrolled early in gestation and followed for Covid-19 exposure and infection, with follow up of obstetrical outcomes and infant development through the first year of life.

NCT ID: NCT04374773 Active, not recruiting - Pregnancy Related Clinical Trials

Effects of Pregnancy-associated Hormones on THC Metabolism in Women

PrECEPT
Start date: October 19, 2020
Phase: Phase 4
Study type: Interventional

Cannabis use is prevalent among pregnant women, but the effects of use on both the developing fetus and pregnant woman are unknown. Importantly, drug exposure could be influenced by the impact of pregnancy-associated hormones on the metabolism of tetrahydrocannabinol (THC), the main psychoactive component of cannabis. The goal of this study is to determine whether cortisol and estradiol - hormones that rise dramatically during pregnancy - increase the clearance of dronabinol (THC) in reproductive age women to simulate the pregnant state. The collected data will then be used to predict the time course and magnitude of changes in THC metabolism in pregnant women, particularly with gradually increasing estradiol and cortisol concentrations that evolve over the course of pregnancy. The overall objective of this study is to better understand the effects of THC use during pregnancy on the health of the pregnant woman and developing fetus.

NCT ID: NCT04359472 Active, not recruiting - Pregnancy Related Clinical Trials

The Collection and Application of Autologous Amniotic Fluid at Cesarean Delivery Closure.

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the feasibility of collecting amniotic fluid at delivery that will be immediately processed and then applied as a spray to the various layers of cesarean wound closure.

NCT ID: NCT04337294 Active, not recruiting - Covid19 Clinical Trials

Evaluation of Blood Results of Covid 19 Positive Pregnants

Start date: March 21, 2020
Phase:
Study type: Observational [Patient Registry]

Evaluation of blood results of covid 19 positive pregnant patients

NCT ID: NCT04337281 Active, not recruiting - Covid19 Clinical Trials

Evaluation of the Effect of High-dose Vitamin C Use in Covid 19 Positive Pregnants

Start date: April 1, 2020
Phase:
Study type: Observational [Patient Registry]

Evaluation of the effect of high-dose vitamin C use in covid 19 positive pregnants

NCT ID: NCT04286217 Active, not recruiting - Pregnancy Related Clinical Trials

SD-OCT Measurement of the Human Retina in Pregnancy With Pre-existing or De Novo Hypertension and Without Hypertension

Start date: October 30, 2013
Phase:
Study type: Observational

The complications of long-standing severe and acute severe elevations in systemic blood pressure (hypertension) may involve large vessels as well as smaller vessels, these latter comprising what is known as the microcirculation. Diseases of the microcirculation include stroke, dementia, and end stage renal disease to name a few. The microcirculation of the brain (and kidneys) possess a reflex called autoregulation that protects the downstream organ from fluctuations in blood pressure and blood flow. The neurosensory retina of the eye is a forward extension of brain and has a similar microcirculation to that of brain, including the presence of blood retinal barriers and the ability to autoregulate. One of the consequences of very severe hypertension is breakthrough of the autoregulatory reflex with hyperperfusion injury and edema formation. Currently, physicians and scientists have no tools to visualize or measure the human microcirculation or the autoregulatory reflex. SD-OCT is an advanced imaging technology that has a spatial resolution 1000-10,000 times greater than CT or MRI. It is the standard of care for identification and follow-up of structural diseases of the eye. The question this research proposal attempts to answer is whether SD-OCT is able to detect edema or other evidence of structural damage in the eyes in patients in the midst of, or following an episode of very severe hypertension. Pregnant women were chosen to be the focus of this study because: 1) pregnant women are generally young and would be expected to possess a normal microcirculation, 2) the occurrence of new-onset hypertension in pregnancy is high, occurring in 5-10% of all pregnancies, 3) there are established prediction rules that allow one to select and compare women at high- or low-risk of developing hypertension in pregnancy, and finally 4) the spectrum of hypertensive injury in pregnancy ranges from minor elevations in systemic blood pressures to eclampsia, the most severe, life-threatening form of hypertensive injury possible. All this is occurs within a 9-month time window defining human pregnancy. Thus, the investigators are proposing to examine the eyes of women using SD-OCT at low- and high-risk of developing hypertension in pregnancy to determine if, when and how this injury is occurring and its relationship to blood pressures.

NCT ID: NCT04253626 Active, not recruiting - Pregnancy Related Clinical Trials

Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia

Start date: January 21, 2021
Phase: Phase 3
Study type: Interventional

Evaluate the extent to which treatment of iron deficiency anemia beyond 24-34 weeks' gestation of pregnancy with intravenous iron increases hemoglobin compared to oral iron. The investigators will test the hypothesis that pregnant women who are anemic in the second and third trimester are more likely to significantly increase their hemoglobin with intravenous iron as opposed to the usual standard of care, oral iron.